Fish Oil Omega-3 Fatty Acid Research

Scientific research supporting the claim that Omega-3 Fatty Acids help Support a Balanced Mood. Fish Oil Home Hamazaki, T., S. Sawazaki, T. Nagasawa, Y. Nagao, Y Kanagawa, and K. Yazawa. "Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at time of psychological stress." Lipids 34:S33-S37 (1999). Hamazaki, T., M. Itomura, S. Sawazaki, and Y. Nagao. "Anti-stress effects of D. H. A." Biofactors 13:41-45 (2000). Hamazak T., Thienprasert A., Kheovichai K., Samuhaseneetoo S., Nagasawa T., Watanabe S. “The effect of docosahexaenoic acid on aggression in elderly Thai subjects--a placebo-controlled double-blind study.” Nutr Neurosc 5(1):37-41 (2002). Adams. P., S. Lawson, A. Sanigorski, and A.J. Sinclair. "Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression." Lipids 31:S157-S161 (1996). Burgress, J. R., L. Stevens, and L. Peck. "Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder." Am J Clin Nutr 71:327S-330S (2000). Hamazaki, T., S. Sawazaki, M. Itomura, E. Asaoka, Y. Nagao, N. Nishimura, K. Yazawa, T. Kuwamori, and M. Kobayashi. "The effect of docosahexaenoic acid on aggression in young adults." J Clin Invest 97:1129-1134 (1996). Hamazaki, T., S. Sawazaki, M. Itomura, Y. Nagao, A. Thienprasert, T. Nagasawa, and S. Watanabe. "Effect of docosahexaenoic acid on hostility." World Rev Nutr Diet 88:47-52 (2001). Maes, M. "Fatty acid composition in major depression: Decreased n-3 fractions in cholesterol esters and increased C20:46/C20:5n3 ratio in cholester ester and phosopholipds. J Affect Dis 38:35-46 (1996). Maes, M., A Christophe, J. Delanghe, C. Altamura, H. Neels, and H.Y. Meltzer. "Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesterol esters of depressed patients." Psychiatry Res 85:275-291 (1999). Stoll, A. L., E. Severus, M. P. Freeman, S. Reuter, H. A. Zhoyan, E. Diamond, K. K. Cress, and L. B. Marangell. "Omega-3 fatty acids in bipolar depression: A preliminary double-blind placebo-controlled trial." Arch Gen Psychiatry 56:407-412 (1999). Voigt, R. G., A. M. Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta, and W. C. Heird. "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder." J Pediatr 139:189-196 (2001). Yehuda, S., S. Rabinovitz, R. L. Carasso, and D. I. Mostofsky. "Essential Fatty acid preparation improves Alzheimer's patients' quality of life." Int J Neurosci 87:141-149 (1996). Mills, D. E., K. M. Prkochin, K. A. Harvey, and R. P. Ward. "Dietary fatty acid supplementation alters stress reactvity and performance in man." J Human Hypertension 3:111-116 (1989). Peet, M., J. Brind, C. N. Ramchand, S. Shah, and G. K. Vankar. "Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia." Schizophr Res 49:243-251 (2001). Richardson, A.J., et al. “Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. “ European Neuropsychopharmacology 10 :189-93 (2000). Stoll, Andrew L., et al. “Omega 3 fatty acids in bipolar disorder.” Archives of General Psychiatry 56:407-12 (1999).